Prelude Therapeutics, Inc. (PRLD)

3.63 +0.03 (+0.83%) USD  |  NASDAQ  |  Oct 23, 16:00
3.64 +0.01 (+0.28%) After-Hours: 20:00
More

Prelude Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for PRLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS LT Growth Estimates Data

View and export this data back to . Start Trial.
Date Value

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Q32 Bio, Inc. --
Intellia Therapeutics, Inc. --
Twist Bioscience Corp. --
Beam Therapeutics, Inc. --
Revolution Medicines, Inc. --